
HHSãåäŸããã£ãŒã³ãåŠå©Šãžã®COVIDã¯ã¯ãã³æšå¥šãäžæ¢ã WSJå ±é
å èšäºã¯ãã¡ããã/Click here to read the original article.
ãŠã©ãŒã«ã»ã¹ããªãŒãã»ãžã£ãŒãã«ãæšææ¥ã«å ±ãããšããã«ãããšãç±³åœä¿å¥çŠç¥çïŒHHSïŒã¯åŠå©Šãåã©ããããã³ãã£ãŒã³ãšã€ãžã£ãŒã«å¯ŸããCOVID-19ã¯ã¯ãã³ã®æšå¥šãäžæ¢ããèšç»ãç«ãŠãŠããã
ã¯ã¯ãã³ã«æ¹å€çãªäººã
ã¯ããã®æ±ºå®ã¯ããã£ãšåã«ãããã¹ãã ã£ãããšè¿°ã¹ãHHSãã¯ã¯ãã³ãåžå Žããæ€å»ãã¹ãã ãšäž»åŒµããŠããã
äžæ¹ã§ãç±³åœç£ç§å©Šäººç§åŠäŒïŒACOGïŒã¯ãã¯ã¯ãã³ã¯äŸç¶ãšããŠãåŠå©Šãèªèº«ãšåŠåš ãå®ãããã®æåã®æ¹æ³ãã§ãããšè¿°ã¹ãŠããã
ç±³åœä¿å¥çŠç¥çïŒHHSïŒãåŠå©Šã»åã©ãã»ãã£ãŒã³ãšã€ãžã£ãŒãžã®COVID-19ã¯ã¯ãã³æ¥çš®ã®æšå¥šãäžæ¢ããèšç»ââãŠã©ãŒã«ã»ã¹ããªãŒãã»ãžã£ãŒãã«å ±é
ãŠã©ãŒã«ã»ã¹ããªãŒãã»ãžã£ãŒãã«ïŒWSJïŒãæšææ¥ã«å ±ãããšããã«ãããšãç±³åœä¿å¥çŠç¥çïŒHHSïŒã¯åŠå©Šãåã©ããããã³ãã£ãŒã³ãšã€ãžã£ãŒã«å¯ŸããŠãCOVID-19ã¯ã¯ãã³ã®å®æçãªæ¥çš®ãæšå¥šããæ¹éãåããããäºå®ã ãšããã
çŸåšãç±³çŸç äºé²ç®¡çã»ã³ã¿ãŒïŒCDCïŒã¯ãçåŸ6ãæä»¥äžã®ãã¹ãŠã®åã©ãã«COVID-19ã¯ã¯ãã³ãæ¥çš®ããããæšå¥šããŠãããCOVID-19ã¯ã¯ãã³ã¯åŠå©Šã«æšå¥šããã4çš®é¡ã®ã¯ã¯ãã³ã®ãã¡ã®ã²ãšã€ãšãªã£ãŠããã
WSJã«ãããšãCDCã¯æ°æ¥ä»¥å ã«ãã®æšå¥šã倿ŽããèŠèŸŒã¿ã§ãããšãååã®æããããŠããªãé¢ä¿è ãèªã£ãŠããããã ããHHSãCDCããã¯ã€ãããŠã¹ã®å ±éå®ã¯ãWSJã®åãåããã«å¯ŸããŠãã仿¥ã®ãã¶ã»ãã£ãã§ã³ããŒãçŽã®åãåããã«å¯ŸããŠããã³ã¡ã³ããè¿ããŠããªãã
åçŽã¯ãHHSãæšå¥šãå®å šã«æ€åããã®ãããããšãæ£è ã«å¯Ÿãå»åž«ãšãªã¹ã¯ãšå©çã«ã€ããŠçžè«ããããä¿ãã®ãã«ã€ããŠã¯ãçŸæç¹ã§ã¯æããã§ãªããšå ±ããŠããã
WSJã®å ±éãæ£ãããã°ããã®æ¹é転æã¯ãç±³é£åå»è¬åå±ïŒFDAïŒãèšç»ããŠããã¯ã¯ãã³æ¿èªå¶åºŠã®æ°ããªæ çµã¿ã®å°å ¥ãšææãåããããããšã«ãªãã
FDAé·å®ã®ããŒãã£ã»ãã«ãªãŒæ°ã¯æšææ¥ããæ°ããªæç¢ºãªå©çã瀺ã蚌æ ãåºãªãéããç§ã¯è¥ããŠå¥åº·ãªåã©ããã¡ã«COVIDã¯ã¯ãã³ãæšå¥šãããªããã°ã匷å¶ãããªãããšWSJã«èªã£ããšããã
ãã®æšå¥šæ¹éã®å€æŽã¯ãéå»4幎éã«ãããCDCã®COVID-19æ¿çããã®å€§ããªè»¢æãšãªãã ãããããããããã¯HHSé·å®ãããŒãã»Fã»ã±ããã£ã»ãžã¥ãã¢æ°ãäžè²«ããŠäž»åŒµããŠããããCOVID-19ã¯ã¯ãã³ã¯åã©ããå«ããã¹ãŠã®äººã«æ·±å»ãªå®å šæ§ã®ãªã¹ã¯ãããããããšããèŠè§£ãšäžèŽããŠããã
COVID-19ã¯ã¯ãã³ã«æ¹å€çãªç«å Žã®äººã ã¯ãã®ãã¥ãŒã¹ãæè¿ããŠãããå€ãããé ãããæ±ºæã ããšèªããšãšãã«ãä¿å¥åœå±ã«å¯ŸããŠãããªã峿ã®å¯Ÿå¿ãæ±ããŠããã
åã©ãã®å¥åº·ãå®ãå£äœãChildrenâs Health DefenseïŒCHDïŒãã®CEOãã¡ã¢ãªãŒã»ãã©ã³ãæ°ã¯ãã¶ã»ãã£ãã§ã³ããŒãã«å¯ŸããŠä»¥äžã®ããã«èªã£ãïŒ
ãCHDã¯ãCOVIDã¯ã¯ãã³ãåã©ããã¡ã«æšå¥šãããåœåããå察ããŠããŸãããããã¯ããã¹ãŠã®å°å çšã¯ã¯ãã³ãå®éã®ç§åŠã«åºã¥ããŠåè©äŸ¡ããããã®éèŠãªç¬¬äžæ©ã«éããŸãããã
å¿èå°éå»ã§COVID-19ã¯ã¯ãã³ã®å±éºæ§ã«ã€ããŠå€ãã®è«æãçºè¡šããŠããããŒã¿ãŒã»ããã«ããŒå»åž«ã¯ããè¿°ã¹ãïŒ
ã2人ã®å€§çµ±é ã3人ã®HHSé·å®ã3人ã®FDAé·å®ããããŠ5幎è¿ãç¶ããCOVIDã¯ã¯ãã³ã®æ²æšãªå€±æãçµãŠã女æ§ãšåã©ããã¡ã¯ããããæè¿ãã¹ããã¥ãŒã¹ãåãåãããšãã§ããŸããã
èšé²çãªæ°ã®ã¯ã¯ãã³è¢«å®³ãéå®³ãæ»äº¡ãèµ·ãã£ãä»ãã¢ã¡ãªã«åœæ°ã¯ããããã®æå°è ãã¡ã¯è²¬ä»»ãåãããã®ãïŒããšçåã«æã£ãŠããŸããããç§ããã®ãããªæš©éãæã€ç«å Žã«ãããªãã2020幎12æã®æç¹ã§ã¯ã¯ãã³èšç»ãå šé¢çã«äžæ¢ããæ°åäžäººã®ã¢ã¡ãªã«äººã®åœãæã£ãŠããã§ããããã
HHSã®æ¹é転æã¯ãã¯ã¯ãã³ã«ãã被害ã«å¯Ÿãã説æè²¬ä»»ãæ±ããåºç¯ãªåããšäžèŽããŠãããmRNAã¯ã¯ãã³æ¥çš®ã®çµäºãæ±ãã声ãšãé£åããŠãããšãç«åŠè ãã³ã©ã¹ã»ãã«ã·ã£ãŒæ°ã¯è¿°ã¹ãã
çŸåšã11ã®å·ãã¯ã¯ãã³çŠæ¢ã«åããæ³æ¡ãæåºããŠãããæ°äžäººã«ããã¶å»åž«ãç§åŠè ãåžæ°ãæ¿æ²»å®¶ãã¡ãCOVID-19ã¯ã¯ãã³ã®åžå Žããã®å®å šæ€åãæ±ããŠãããšããã
åã©ããžã®æ¥çš®ã«ã¯æ¢ç¥ã®å±éºæ§ããã£ãââãéãã¯ãŸã çµãã£ãŠããªãã
ãã³ãããã¯ã®æäžã§ãããå°éå®¶ãã¡ã¯åã©ããCOVID-19ã«ããéçåãªã¹ã¯ã¯æ¥µããŠäœãããšã«åæããŠããããŸããã¯ã¯ãã³ã®æ¿èªçŽåŸã«ã¯ãç¹ã«è¥å¹Žå±€ã«ãããŠå¿ççãå¿èçãšã®é¢é£ãæããã«ãªãããã®ä»ã«ãå€ãã®ãªã¹ã¯ãææãããã
ããã«ãããããããå ¬è¡è¡çåœå±ã¯åœåãã16æ³ä»¥äžãžã®æ¥çš®ãæ¿èªãã2021幎5æã«ã¯12æ³ä»¥äžã«å¯Ÿè±¡ãæ¡å€§ãããFDAïŒç±³é£åå»è¬åå±ïŒã¯2021幎10æã«5æ³ä»¥äžã®åã©ããžã®æ¥çš®ãæ¿èªãã2022幎6æã«ã¯çåŸ6ãæä»¥äžã®ä¹³å ã«ãé©çšç¯å²ãåºããã
12æ³æªæºã®åã©ããžã®COVID-19ã¯ã¯ãã³ã¯æ£åŒãªFDAæ¿èªãåŸãŠããããçŸåšãç·æ¥äœ¿çšèš±å¯ïŒEUAïŒã®ãŸãŸã ããCDCïŒçŸç äºé²ç®¡çã»ã³ã¿ãŒïŒã¯2023幎2æãåæ©é¢ã®è«®åå§å¡äŒã«ããå šäŒäžèŽã®æšå¥šãåããCOVID-19ã¯ã¯ãã³ãå°å ããã³æäººã®å®æäºé²æ¥çš®ã¹ã±ãžã¥ãŒã«ã«è¿œå ããã
ä»é±åãããã¹ããŒãã»ãã ãºã»ã¢ã¹ã¯ããã£ã³ããŒã³ã®äž»å¬è ã®äžäººã§ããã«ããã»ãªã³ããªãŒå»åž«ã¯ãé£éŠä¿å¥åœå±ã«å¯ŸããCOVID-19ã¯ã¯ãã³ãå°å åãäºé²æ¥çš®ã¹ã±ãžã¥ãŒã«ããå€ãããæ±ããæŽ»åãå±éããŠãããä»åã®æ±ºå®ããåã©ããã¡ã®ããã«éã£ãŠãã芪ãã¡ã®åå©ããšè¡šçŸããããªã³ããªãŒå»åž«ã¯ãæ¯èŠªã芪ãã¡ãç¬ç«ç³»ã®å»åž«ãã¡ãšå£çµããã°ã倧ããªåãåãããåã©ããã¡ãå®ãããšãã§ããããšè¿°ã¹ãã
圌女ã¯ãŸããHHSããã®æ£åŒãªåœä»€ææžã確èªããããšãããããã«ãã£ãŠããã®æ¿æš©ã®çæãåããããšèªã£ããããã«ããã®éãã¯ãŸã çµãã£ãŠããªããä»åŸã¯å®å šãªã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ãïŒååãªèª¬æãšåæïŒãå¿ èŠã§ããããã¹ãŠã®å¹Žéœ¢å±€ãžã®æšå¥šãæ€åãã¹ãã ããšãè¿°ã¹ãŠããã
å°å ç§å»ã®ãµãã©ã»ã«ã«ããã¹å»åž«ããæ£åŒãªçºè¡šããŸã ãªãããŠããªã以äžã詳现ã確èªããããšãéèŠã ãšãããã®å€æŽãããŸãã«ãé ãããããšãææããåã©ããã¡ã®åœãããã£ãŠããããšè¿°ã¹ãã
GMOç§åŠã®CEOã§ããå°å ç§å»ã®ãã·ã§ã«ã»ããå»åž«ã¯ãããã®ãããªæ±ºå®ãããããäžãããããšã¯ãçŸåšã®ç§åŠçç¥èŠã«å³ããå ¬è¡è¡çæ¿çãžã®é©å¿ãæå³ããããšãã¶ã»ãã£ãã§ã³ããŒãçŽã«èªã£ãã
ãç§ã®ææ¡ãšããŠã¯ãHHSãããã«äžæ©èžã¿åºããFDAããã¹ãŠã®å°å åãmRNAéºäŒåå ç«èª¿æŽå€ã忢ããããåããããã¹ãã§ãããšåœŒå¥³ã¯è¿°ã¹ããããããã®æ³šå°ã¯ãæ£äœäžæã®DNAæçã§æ±æãããŠããããšã瀺ãããŠããããããåã©ãã®éºäŒåã«åœ±é¿ãäžããæ°å€ãã®æ·±å»ãã€è€éãªæ ¢æ§çŸæ£ã®åå ã«ãªã£ãŠããã®ã§ããã
ACOGãåŠå©Šãžã®COVIDã¯ã¯ãã³æšå¥šãæ¹ããŠåŒ·èª¿
ãžã£ãŒããªã¹ãã§ããã€ãªãŒã»ã¯ã©ãŠãïŒDaily CloutïŒãã®CEOã§ããããªãã»ãŠã«ãæ°ã¯ããã¶ã»ãã£ãã§ã³ããŒãçŽã«å¯Ÿããä»åã®çºè¡šã¯æè¿ãã¹ããã¥ãŒã¹ã ãšèªã£ããããã圌女ã¯åæã«ã次ã®ããã«ãè¿°ã¹ãŠããïŒ
ãããã¯ãŸããã©ã®æ¿æš©ã«ãšã£ãŠãè ¹ç«ãããã»ã©é ããã察å¿ã§ããç§ã¯2021幎7æã®æç¹ã§ãmRNAã¯ã¯ãã³ãçæ®èœåã«æªåœ±é¿ãåãŒããšèŠåããŠããŸãããã
ãŠã«ãæ°ã¯ããã«ããç¶ããïŒ
ã2023幎以éãç§ã®ããŒã ââWarRoomïŒDailyCloutã®ç ç©¶è ãã¡ã¯ãã¡ã€ã¶ãŒã®å éšè³æã䜿ã£ãŠãã¯ã¯ãã³ãå¥åº·ãªæªæå¹Žã®å¿èã«ãã¡ãŒãžãäžããèå ãèå ã®èµ€ã¡ãããæ»ã«è³ããã女æ§ã®åµå·£æ©èœãé»å®³ãããããŠããããCOVIDãé²ãããšãã§ããªãã£ããšããäºå®ãæããã«ããŠããŸããã
次ã®å³æã®ã¹ãããã¯ããã®èŽåœçãªã¯ã¯ãã³ãåžå Žããæ€å»ãã**PREPæ³ïŒå ¬è¡è¡çç·æ¥æºåæ³ïŒ**ãæ€åããŠã補é å ã責任è ãã¡ã«å¯Ÿããæ³çæªçœ®ãå¯èœã«ãªãããã«ããããšã§ããã
Daily Cloutã«ãããã¡ã€ã¶ãŒã®èšåºè©ŠéšããŒã¿ã®åæã§ã¯ãæ¥çš®ãæµç£ãæ©ç£ãšé¢é£ããŠããããšã瀺ãããããŸãããã¡ã€ã¶ãŒã®åŠåš ããã³æä¹³ã«é¢ããå ±åæžã«ã¯ãçºç±ãååãæµ®è «ïŒããã¿ïŒãªã©ãæä¹³äžã®ä¹³å ãžã®å€æ°ã®å¯äœçšãèšãããŠããã
ãã¡ã€ã¶ãŒã¯ãã®å ±åæžã2021幎4æ20æ¥ã«FDAã«æåºãããããã®3æ¥åŸã®4æ23æ¥ãCDCã®ãã·ã§ã«ã»ã¯ã¬ã³ã¹ããŒæé·ã¯ãã¯ã€ãããŠã¹ã§èšè äŒèŠãè¡ãã女æ§ã«å¯ŸããŠãåŠåš åã»åŠåš äžã»åºç£åŸããã€æ¥çš®ããŠãåé¡ãªãããšçºèšããŠããã
ã¢ã¡ãªã«å°å ç§åŠäŒïŒAAPïŒãã¢ã¡ãªã«ç£å©Šäººç§åŠäŒïŒACOGïŒãªã©ã®å»åŠå£äœã¯ããããŸã§äžè²«ããŠåã©ããšåŠå©Šãžã®COVIDã¯ã¯ãã³æ¥çš®ãæ¯æããŠããããã®æšå¥šå 容ã¯éåžžãCDCã®æ¹éãšäžèŽããŠããã
ãã¶ã»ãã£ãã§ã³ããŒãã¯ãHHSã®æ¿ç倿ŽãåããŠããããã®å£äœãæšå¥šå 容ãèŠçŽãäºå®ããããã©ããåãåãããè¡ã£ãã
ACOGã®èšåºå®è·µéšé責任è ã§ããã¯ãªã¹ããã¡ãŒã»ã¶ãŒã³å»åž«ã¯ãCDCããå šå¯Ÿè±¡è ããžã®æ¥çš®æšå¥šãšããªã¹ã¯ã«å¿ãããæšå¥šã®ã©ã¡ãã«ããããæ€èšããŠããããšã¯ææ¡ããŠãããšããªãããã**ãèšåºäžã®æšå¥šã«å®éã®å€æŽã¯ãŸã è¡ãããŠããªãã**ãšçããã
ã¶ãŒã³å»åž«ã¯ããã«æ¬¡ã®ããã«è¿°ã¹ãïŒ
ãACOGã®ãšããã³ã¹ã«åºã¥ãæšå¥šã¯ããã¹ãŠã®åŠå©ŠãCOVID-19ã¯ã¯ãã³ãæ¥çš®ããããšãæ¯æããŠããŸãã
åŠå©Šã¯éçåãããªã¹ã¯ãé«ããåŠåš å䜵çãæ»äº¡ã®ãªã¹ã¯ãé«ãŸããŸããã¯ã¯ãã³æ¥çš®ã¯ãåŠå©Šãèªåèªèº«ãšåŠåš ãå®ãããã®æåã®æ¹æ³ã§ãããšããç¹ã«å€ããã¯ãããŸãããã
ãªããAAPïŒç±³åœå°å ç§åŠäŒïŒã¯ãèšäºã®ç· åãŸã§ã«ã³ã¡ã³ããè¿ããŠããªãã
CDCã«ããã°ã2024幎4æ26æ¥æç¹ã§ãæŽæ°çã®COVID-19ã¯ã¯ãã³ãæ¥çš®ããåŠå©Šã¯çŽ14%ãåã©ãã¯çŽ13%ã«ãšã©ãŸã£ãŠããã